FARMACOCINÉTICA EXPERIMENTAL Y CLÍNICA
National Cancer Institute
Rockville, Estados UnidosNational Cancer Institute-ko ikertzaileekin lankidetzan egindako argitalpenak (4)
2023
-
Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: An international multicentre analysis
CMAJ. Canadian Medical Association Journal, Vol. 66, Núm. 3, pp. E310-E320
2020
-
Prognostic gene expression signature for high-grade serous ovarian cancer
Annals of Oncology, Vol. 31, Núm. 9, pp. 1240-1250
2015
-
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer
Clinical Cancer Research, Vol. 21, Núm. 3, pp. 652-657
-
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
Nature Genetics, Vol. 47, Núm. 2, pp. 164-171